Simvastatin cream for eyelid cholesterol deposits
Part of Hormones & metabolism clinical trials.
This study tests a cream containing simvastatin (commonly a cholesterol pill, now as a cream) to see if it can shrink fatty deposits on the eyelids. If you have these yellowish patches, using the cream might help reduce them without needing a procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have xanthelasma—small yellowish cholesterol patches on or near your eyelids—that a doctor can see.
- You must have at least one measurable patch (not just a tiny speck) that can be evaluated.
- You must not have had any procedure to remove these patches in the last 3 months (like laser, freezing, or surgery).
- You must be willing to use only this study cream and not any other xanthelasma treatments during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new minimally invasive procedure using tiny tunnels and a heparin injection to treat xanthelasma (cholesterol deposits under the skin of the eyelids). It may help reduce the appearance of these deposits with less scarring than traditional methods.
This trial tests a cream containing simvastatin, a cholesterol medicine, applied to infantile hemangiomas (strawberry birthmarks) in babies aged 3-6 months. It may help shrink the birthmark without needing stronger treatments.
This trial tests whether simvastatin (a cholesterol medicine) can improve eye symptoms from Graves’ eye disease. It is aimed at people with active mild-to-moderate disease and will also check safety with blood tests, heart/skin tolerance, and stomach health.
This trial compares a cholesterol-lowering cream (simvastatin) with a standard steroid cream to treat patchy hair loss from alopecia areata. It aims to find a gentler, more effective way to help hair regrow on the scalp.
This study tests a medicated eye drop (lotilaner) to treat eyelid mite inflammation (Demodex blepharitis) in people who wear PROSE scleral lenses. It aims to see if the drops safely reduce symptoms like redness, itching, and blurry vision.
This trial tests a 2% cholesterol cream to see if it helps children with mild to moderate eczema on their inner elbows. It's designed for Thai children aged 7 to 17 who are not using strong immune-suppressing drugs.
Hear when a new Xanthelasma Palpebrarum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.